Table 4 Association of patient IL-1ß (promoter region and exon-5 in rejecters (RE) and non-rejecters (SGF)
No. | Haplotype | Patient (%) | Control (%) | p-value | OR | RE (%) | SGF (%) | p-value | OR(RE vs. SGF) |
|---|---|---|---|---|---|---|---|---|---|
1 | C/E1 | 47 (23.3) | 87 (21.8) | 0.673 | 1.091 | 10 (16.7) | 37 (26.1) | 0.149 | 0.568 |
2 | C/E2 | 75 (37.1) | 110 (27.5) | 0.016 | 1.557 | 25 (41.7) | 50 (35.2) | 0.568 | 0.386 |
3 | T/E1 | 33 (16.3) | 90 (22.5) | 0.077 | 0.673 | 8 (13.3) | 25 (18.6) | 0.453 | 0.72 |
4 | T/E2 | 47 (23.3) | 113 (28.2) | 0.191 | 0.77 | 17 (28.3) | 30 (21.1) | 0.268 | 1.476 |